Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers

Project Information

Curtana

Grant agreement ID: 762351

DOI 10.3030/762351

Project closed

EC signature date 31 January 2017

Start date 1 February 2017

End date 31 May 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

CURTANA PHARMA LTD
United Kingdom